Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Harvard Bioscience

Start price
Target price
Perf. (%)
€2.60
10.03.23
€3.77
10.03.24
51.54%
11.03.24

buy
Alphatec Holdings Inc

Start price
Target price
Perf. (%)
€14.88
08.03.23
-
08.03.24
0.17%
31.01.24

buy
Addus Homecare Corp.

Start price
Target price
Perf. (%)
€95.50
06.03.23
€115.36
06.03.24
-6.28%
07.03.24

buy
Pro-Dex Inc.

Start price
Target price
Perf. (%)
€15.00
05.03.23
-
05.03.24
2.67%
06.03.24

buy
SI-BONE Inc

Start price
Target price
Perf. (%)
€18.30
28.02.23
€24.47
28.02.24
-14.21%
29.02.24

buy
Nemaura Medical Inc

Start price
Target price
Perf. (%)
€0.51
28.02.23
€5.64
28.02.24
-
29.02.24

buy
ViewRay Inc

Start price
Target price
Perf. (%)
€4.14
28.02.23
€7.52
28.02.24
-98.76%
29.02.24

buy
Addus Homecare Corp.

Start price
Target price
Perf. (%)
€100.00
28.02.23
-
28.02.24
-16.50%
29.02.24

Avinger Inc.

Start price
Target price
Perf. (%)
€1.00
27.02.23
-
27.02.24
-66.20%
28.02.24

buy
Pro-Dex Inc.

Start price
Target price
Perf. (%)
€14.00
26.02.23
-
26.02.24
7.86%
27.02.24

buy
Sientra Inc.

Start price
Target price
Perf. (%)
€1.84
02.02.23
€3.60
02.02.24
-4.62%
06.02.23

Could be very worthwhile Investment >20% year
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€43.10
09.01.23
-
09.01.24
-0.35%
21.01.23

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€38.00
09.01.23
-
09.01.24
-1.05%
21.01.23

Fair valuation
Top 10 in its market
Future proof or reliable business model
Could be worthwhile Investment >10% per year
buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€34.35
22.12.22
-
22.12.23
13.25%
24.08.23

buy
M1 Kliniken AG

Start price
Target price
Perf. (%)
€6.04
09.12.22
-
09.12.23
68.87%
10.12.23

buy
Mediclin AG

Start price
Target price
Perf. (%)
€3.32
13.11.22
€3.00
13.11.23
-0.60%
26.11.22

EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
buy
Motus GI Holdings Inc.

Start price
Target price
Perf. (%)
€2.12
24.10.22
€3.00
24.10.23
-73.07%
25.10.23

Could be worthwhile Investment >10% per year
Carmat

Start price
Target price
Perf. (%)
€12.25
22.10.22
€10.00
22.10.23
-72.94%
23.10.23

Could be worthwhile Investment >10% per year
Motus GI Holdings Inc.

Start price
Target price
Perf. (%)
€1.97
10.10.22
€0.000
10.10.23
-6.09%
16.10.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Decining EBIT margin than peer group
buy
Motus GI Holdings Inc.

Start price
Target price
Perf. (%)
€2.26
03.10.22
€3.00
03.10.23
22.12%
06.10.22

Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Little innovation
buy
scPharmaceuticals

Start price
Target price
Perf. (%)
€6.15
29.09.22
€8.00
31.12.24
-23.25%
10.10.22

Could be very worthwhile Investment >20% year
Vivani Medical Inc.

Start price
Target price
Perf. (%)
€2.81
19.09.22
-
19.09.23
-67.84%
24.04.23

Probably not worthwhile Investment
buy
Ocular Therapeutix Inc.

Start price
Target price
Perf. (%)
€5.70
07.09.22
€10.00
31.12.24
8.78%
04.07.24

Could be very worthwhile Investment >20% year
buy
ShockWave Medical Inc

Start price
Target price
Perf. (%)
€285.40
07.09.22
€400.00
31.12.25
-47.00%
12.11.23

Could be very worthwhile Investment >20% year
Nuwellis Inc.

Start price
Target price
Perf. (%)
€1.69
31.08.22
-
31.08.23
-93.25%
18.05.23

Could be very worthwhile Investment >20% year